MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SEPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Septerna (SEPN) Ownership - Who owns Septerna?

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
250 East Grand Avenue
Phone
+1 650 338-3533
Employees
130
Web
https://www.septerna.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.8B
P/E Ratio
N/A
Total Cash
372.32M
Projected Growth
N/A
Total Debt
22.55M
Revenue
98.88M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.98
Total Debt/Equity
N/A
Revenue/Share
2.21 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
SEPN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for SEPN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
250 East Grand Avenue
Phone
+1 650 338-3533
Employees
130
Web
https://www.septerna.com
Who owns Septerna? SEPN symbol Ownership - Tickeron.com